Kolexia
Iacob Mariana Oncologie médicale
Iacob Mariana
Oncologie médicale
Gustave-Roussy
Villejuif, France
45 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome épidermoïde Carcinomes Carcinome épidermoïde de la tête et du cou Tumeurs de la tête et du cou Polykystose rénale autosomique dominante Polykystoses rénales Syndrome des anticorps antiphospholipides Maladies du rein Hypertension artérielle

Collaborateurs

Voir plus
Even Caroline
Even Caroline
Gustave-Roussy, Villejuif, France
Joannides Robinson
Joannides Robinson
Hôpital Charles Nicolle, Rouen, France
Ferrand Francois-Régis
Ferrand Francois-Régis
Hopital Instruction des Armees Begin, Saint-Mandé, France
Matias Margarida
Matias Margarida
Gustave-Roussy, Villejuif, France

Industries

Voir plus
MSD
2 collaboration(s)
Dernière en 2022
Merck-Serono
1 collaboration(s)
Dernière en 2022
Vifor
1 collaboration(s)
Dernière en 2020
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
940P Salvage chemotherapy after progression on nivolumab in patients with squamous cell carcinoma of the head and neck included in the phase II TOPNIVO trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
855MO Adjuvant immunotherapy after salvage surgery in head and neck cancer squamous cell carcinoma (HNSCC): Phase II trial evaluating the efficacy and the toxicity of Nivolumab (ADJORL1)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Chronic endothelial dopamine receptor stimulation improves endothelial function and hemodynamics in autosomal dominant polycystic kidney disease (IMPROVE-PKD)
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Hyperactivité monocytaire et dysfonction endothéliale dans l’angiœdème bradykinique héréditaire : étude MONOBRAD
86e CONGRÈS FRANÇAIS DE MÉDECINE INTERNE   01 juin 2023
FRAIL-IMMUNE: Multicenter Prospective Single Arm Phase II Study Evaluating Efficacy & Safety of Durvalumab With Carboplatin/Paclitaxel as First Line Treatment in Patients With Recurrent/Metastatic SCCHN Not Eligible to Standard Chemotherapy
Essai Clinique (Centre Léon-Bérard)   03 octobre 2022
129P Molecular screening and early phase trial inclusion for head and neck squamous cell carcinoma patients
Molecular Analysis for Precision Oncology Congress 2022 14-16 October 2022   01 octobre 2022
675P Patterns of radiological responses to anti-PD1 in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) in TOPNIVO (T) study
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
Efficacy and safety of immune checkpoint inhibitors in elderly patients (≥70 years) with squamous cell carcinoma of the head and neck.
European journal of cancer (Oxford, England : 1990)   15 septembre 2021
916P Impact of sarcopenia (S) on efficacy and toxicity of nivolumab (N) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) in TOPNIVO (T) study
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
Panitumumab as an effective maintenance treatment in metastatic squamous cell carcinoma of the head and neck.
Oral oncology   01 septembre 2020